Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carbon-Ion Pencil Beam Scanning Treatment With Gated Markerless Tumor Tracking: An Analysis of Positional Accuracy.
Mori S, Karube M, Shirai T, Tajiri M, Takekoshi T, Miki K, Shiraishi Y, Tanimoto K, Shibayama K, Yasuda S, Yamamoto N, Yamada S, Tsuji H, Noda K, Kamada T. Mori S, et al. Among authors: shibayama k. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):258-266. doi: 10.1016/j.ijrobp.2016.01.014. Epub 2016 Jan 20. Int J Radiat Oncol Biol Phys. 2016. PMID: 26960747
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM.
Ishida T, Kuroda Y, Matsue K, Komeno T, Ishiguro T, Ishikawa J, Ito T, Kosugi H, Sunami K, Nishikawa K, Shibayama K, Aida K, Yamazaki H, Inagaki M, Kobayashi H, Iida S. Ishida T, et al. Among authors: shibayama k. Int J Hematol. 2024 Nov 28. doi: 10.1007/s12185-024-03884-z. Online ahead of print. Int J Hematol. 2024. PMID: 39607603
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study.
Muta T, Masamoto Y, Yamamoto G, Kurahashi S, Kameoka Y, Ota S, Matsuki E, Ozeki K, Toyama T, Takahashi N, Kumode T, Aotsuka N, Yoshimura T, Tamura H, Omi A, Shibayama K, Watanabe A, Isobe Y, Kojima K, Takizawa J, Nagai H, Suzumiya J, Aoki S. Muta T, et al. Among authors: shibayama k. Int J Hematol. 2024 Nov 26. doi: 10.1007/s12185-024-03875-0. Online ahead of print. Int J Hematol. 2024. PMID: 39586984
Antimicrobial susceptibility analysis of isepamicin combination treatments in Mycobacterium abscessus species.
Kato Y, Ihara H, Takei S, Nakamura A, Fujimoto Y, Handoh T, Kurokawa K, Arai Y, Shibayama K, Sumiyoshi I, Ochi Y, Watanabe J, Hoshi K, Misawa S, Togo S, Naito T, Tabe Y, Miida T, Takahashi K. Kato Y, et al. Among authors: shibayama k. J Clin Tuberc Other Mycobact Dis. 2024 Jul 15;36:100464. doi: 10.1016/j.jctube.2024.100464. eCollection 2024 Aug. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 39099802 Free PMC article.
420 results